-
公开(公告)号:EP2970424A2
公开(公告)日:2016-01-20
申请号:EP14722420.8
申请日:2014-03-12
申请人: Eli Lilly and Company , Ambrx, Inc.
IPC分类号: C07K14/575
CPC分类号: A61K47/48215 , A61K38/2264 , A61K47/60 , C07K14/5759
摘要: Modified canine leptin polypeptides and formulations and uses thereof, are provided including polyethylene glycol (PEG) modified canine leptin polypeptides, wherein the PEG moiety is covalently attached to a para-acetyl-phenylalanine (pAF) residue of the polypeptide, and related compositions and methods useful in treating companion animal obesity and other leptin-related disorders.
摘要翻译: 提供了修饰的犬瘦素多肽及其制剂和用途,包括聚乙二醇(PEG)修饰的犬瘦素多肽,其中PEG部分共价连接到多肽的对 - 乙酰基 - 苯丙氨酸(pAF)残基,以及相关组合物和方法 可用于治疗伴侣动物肥胖症和其他瘦素相关疾病。
-
公开(公告)号:EP2970424B1
公开(公告)日:2017-06-21
申请号:EP14722420.8
申请日:2014-03-12
申请人: Eli Lilly and Company , Ambrx, Inc.
IPC分类号: C07K14/575
CPC分类号: A61K47/48215 , A61K38/2264 , A61K47/60 , C07K14/5759
-